Abstract
3/2022
vol. 97
Case report
Mycophenolate mofetil-related colitis in a paediatric patient after kidney transplant
- Students’ Association, Medical University of Silesia, Katowice, Poland
- Department of Paediatrics, Faculty of Medical Sciences in Zabrze, Students’ Association, Medical University of Silesia, Katowice, Poland
- Department of Nephrology, Kidney Transplantation and Hypertension, the Children’s Memorial Health Institute, Warsaw, Poland
Pediatr Pol 2022; 97 (3): 260-263
Online publish date: 2022/10/18
Mycophenolate mofetil (MMF) is an immunosuppressive agent, the gastrointestinal side effects of which include abdominal pain, diarrhoea, and vomiting. MMF may also cause symptomatic colitis, although it is a rare condition. We present herein the case of a boy with chronic kidney disease, lasting since the neonatal period, and caused by WT1 gene mutation. The patient developed colitis during an immunosuppressive therapy applied after a kidney transplant. Histopathology of intestinal biopsy specimens revealed features of MMF-related colitis. A modification of the immunosuppressive treatment and the implementation of a nutritional programme to the patient resulted in the disappearance of clinical signs and helped in a gradual body weight gain.
Keywords
children, mycophenolate mofetil, kidney transplant, colitis
Integrated with
